Trends in Gram-negative bloodstream infection, antimicrobial use and antimicrobial resistance in Northern Ireland by Nugent, Christopher et al.
Trends in Gram-negative bloodstream infection, antimicrobial use and
antimicrobial resistance in Northern Ireland
Nugent, C., Patterson, L., & Bradley, D. (2018). Trends in Gram-negative bloodstream infection, antimicrobial
use and antimicrobial resistance in Northern Ireland. Poster session presented at 5 Nations Health Protection
Conference, Belfast, United Kingdom.
Document Version:
Other version
Queen's University Belfast - Research Portal:
Link to publication record in Queen's University Belfast Research Portal
Publisher rights
© 2018 The Authors.
General rights
Copyright for the publications made accessible via the Queen's University Belfast Research Portal is retained by the author(s) and / or other
copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated
with these rights.
Take down policy
The Research Portal is Queen's institutional repository that provides access to Queen's research output. Every effort has been made to
ensure that content in the Research Portal does not infringe any person's rights, or applicable UK laws. If you discover content in the
Research Portal that you believe breaches copyright or violates any law, please contact openaccess@qub.ac.uk.
Download date:06. Aug. 2018
Trends in Gram-negative bloodstream infection, antimicrobial  
use and antimicrobial resistance in Northern Ireland 
Christopher Nugent, Lynsey Patterson, Declan T. Bradley 
Health Protection, Public Health Agency, Belfast, Northern Ireland 
Email: chris.nugent@hscni.net 
Introduction: 
Antimicrobial resistance (AMR) is a present 
and growing threat to global human health. 
Gram-negative organisms present a particular 
challenge due to their ability to develop 
resistance, while the inappropriate and 
overuse of antibiotics further accelerates the 
AMR process. The Northern Ireland (NI) 
Department of Health, Social Services and 
Public Safety aimed to ‘establish and maintain 
systems to monitor antimicrobial usage and 
surveillance of resistance’ (DHSSPSNI, 2012). 
The selected results outlined in this poster are 
the product of that system. Full results are 
available at: http://pha.site/AMR2017   
Methods: 
Results: 
Conclusions: 
• There has been an increasing incidence of gram-negative bloodstream 
infections and a small rise in the proportion resistant to selected antibiotics. 
• Rates of antibiotic consumption are stable but substantially higher than other 
parts of the UK. 
• We have limited information about who is receiving antibiotics and who is 
prescribing them.  
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Antibiotic susceptibility testing. Reported to PHA as: 
 
• Susceptible (S): growth inhibited in vitro by a 
concentration of the drug associated with a high 
likelihood of therapeutic success. 
 
• Indeterminate (I): concentration required to inhibit 
growth in vitro associated with uncertain 
therapeutic outcome at standard doses. 
 
• Resistant (R): concentration required to inhibit 
growth  in vitro associated with a high likelihood of 
therapeutic failure. 
 
*I and R grouped together as ‘Non-Susceptible’ for 
reporting purposes. 
 
Recommendations: 
• Further investigation is needed to  identify who is receiving and prescribing 
antibiotics in Northern Ireland. 
• Availability of timely, detailed intelligence for practitioners/managers should 
help target efforts to reduce consumption and inappropriate antibiotic use. 
